Navigation Links
Treating Prostate Cancer: Old School vs. New School
Date:8/24/2009

The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT

Mesa, AZ (Vocus) August 24, 2009 -- New innovations in treating prostate cancer have more than doubled the cure rate for high-risk patients. Traditional proton and photon therapies have an approximate 40% success rate for patients with advanced prostate cancer. In sharp contrast, new combined therapies discussed on Doctorfinders.com, have shown cure rates as high as 98% for patients in expert hands.

An estimated 234,000 new cases of prostate cancer will be diagnosed in the United States this year, making it one of the most common cancers affecting American men, second only to skin cancer. More than 27,000 deaths due to prostate cancer are expected to occur this year.

Prostate cancer is most often diagnosed through a blood test measuring the amount of prostate specific antigens (PSA) in the body. However, signs and symptoms of prostate cancer can include: Changes in urinary flow: frequency, urgency, and hesitancy. Also, frequent nighttime urination, painful urination, or blood in urine.

The good news is that the outlook for men diagnosed with prostate cancer is better than ever. When prostate cancer is detected early, while the tumor is still localized, the survival rate is extremely high.

Dr. Jamie Cesaretti, a prostate cancer specialist with the Florida Radiation Oncology Group and contributor to Doctorfinders.com says, "It is an exciting time in prostate cancer radiotherapy treatment. Old concepts of radiotherapy using standard treatments have largely been replaced with new more precise therapies called image-guided brachytherapy (seed-implants) and/or intensity modulation radiation therapy (IMRT)."

The historically low cure rates offered by traditional radiotherapy and proton therapy are being replaced by almost unbelievable treatment outcomes from the combination of modern brachytherapy and IMRT. "A combination of brachytherapy and IMRT can cure between 98% for low-risk patients, 95% for intermediate risk and 85% for high risk patients in expert hands," says Dr. Cesaretti.

The concept behind the combination treatment is simple; the brachytherapy seed implant causes a minimum amount of symptoms while still targeting the cancer. In addition, the IMRT treatment dose is also lowered to also decrease symptoms. In combination, the two high-tech treatments punish the cancer while leaving most men with an excellent quality of life in terms of their ability to have and maintain an erection and live without bowel and bladder symptoms.

Dr. Cesaretti and his partners perform over 500 prostate seed implants per year. He has a special interest in the treatment of prostate cancer with a combination of IMRT and brachytherapy. Dr. Cesaretti's profile can be found at Doctorfinders.com.

DoctorFinders.com is an innovative tool that allows the general public to easily access information about health concerns and find the right doctor for their needs. The site allows for users to identify doctors by geographic area, specialties, procedures, and more.

###

Read the full story at http://www.prweb.com/releases/Doctors/Prostate_Cancer/prweb2786414.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Study finds low risk in treating previously coiled aneurysm
2. Night home hemodialysis shown to be as good as transplant in treating kidney failure
3. Centers of Excellence Awards Presented to Over 100 Nursing Facilities as Nursing Facilities Reach the Tipping Point in Treating Pressure Ulcers
4. HIV-Treating Clinicians Support Health Care Reform, Express Caution
5. Surgery, Sham Equal in Treating Compression Fracture Pain
6. Genetic testing may be valuable in treating colorectal cancer
7. Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop
8. Lumenis UltraPulse TotalFX Treatment Featured on ABCNews 20/20 as a Secret Weapon for Treating for Burn Scars
9. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
10. Antidepressants aid electroconvulsive therapy in treating severe depression
11. Study in Nature: MicroRNAs hold promise for treating diseases in blood vessels
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Treating Prostate Cancer: Old School vs. New School 
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “America On ... Christian identity. “America On The Brink” is the creation of published author, William ... several great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
Breaking Medicine Technology: